Development and validation of an UPLC–MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats-Reference-Cited by-同舟云学术

Development and validation of an UPLC–MS/MS method for the quantification of irinotecan, SN-38 and SN-38 glucuronide in plasma, urine, feces, liver and kidney: Application to a pharmacokinetic study of irinotecan in rats

Published:2016-03 Issue: Volume:1015-1016 Page:34-41
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Basu Sumit,Zeng Min,Yin Taijun,Gao Song,Hu Ming

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference36 articles.

1. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J. Clin. Oncol.,2004

2. Current status of pharmacological treatment of colorectal cancer;Akhtar;World J. Gastrointest. Oncol.,2014

3. An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma;Ohno;J. Clin. Oncol.,1990

4. A phase II study of CPT-11: a new derivative of camptothecin, for previously untreated non-small-cell lung cancer;Fukuoka;J. Clin. Oncol.,1992

5. Phase II study of CPT-11: a new camptothecin derivative, in metastatic colorectal cancer: CPT-11 Gastrointestinal Cancer Study Group;Shimada;J. Clin. Oncol.,1993

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fecal SN-38 Content as a Surrogate Predictor of Intestinal SN-38 Exposure and Associated Irinotecan-induced Severe Delayed-Onset Diarrhea by a Novel Use of the Spectrofluorimetric Method;Pharmaceutical Research;2024-08-13

2. A validated high‐performance liquid chromatography‐tandem mass spectrometry method for simultaneous determination of irinotecan and two major metabolites in rat plasma: Application for the pharmacokinetics study;SEPARATION SCIENCE PLUS;2024-05-10

3. Optimized rat models better mimic patients with irinotecan-induced severe diarrhea;Toxicology Mechanisms and Methods;2024-02-23

4. Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis;Journal of Chromatography B;2024-02

5. A novel dsDNA decamer-based electrochemical biosensor for selective determination of irinotecan active metabolite - SN38;Sensors and Actuators B: Chemical;2023-12